Rhythm Biosciences Ltd. advised that Mr. Glenn Gilbert has tendered his resignation as Chief Executive Officer and Managing Director of the Company effective 21 April 2023. For the near term, Otto Buttula, Executive Chairman, will assume additional executive duties, spending more time in the Company's Melbourne offices, alongside the Company's expanded executive team.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 AUD | -1.23% | -3.61% | -40.74% |
Apr. 24 | Rhythm Biosciences Appoints CEO; Shares Down 3% | MT |
Mar. 21 | Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.74% | 13.1M | |
-26.80% | 10.94B | |
+65.44% | 3.75B | |
-28.13% | 2.27B | |
-10.06% | 2.25B | |
-25.01% | 1.54B | |
+50.53% | 1.18B | |
-2.84% | 754M | |
-7.83% | 529M | |
-27.35% | 469M |
- Stock Market
- Equities
- RHY Stock
- News Rhythm Biosciences Limited
- Rhythm Biosciences Ltd Announces Executive Changes